FINWIRES · TerminalLIVE
FINWIRES

Enliven Therapeutics Insider Sold Shares Worth $504,903, According to a Recent SEC Filing

By

Lori Anne Kunkel, Director, on July 06, 2026, sold 10,000 shares in Enliven Therapeutics (ELVN) for $504,903. Following the Form 4 filing with the SEC, Kunkel has control over a total of 41,884 common shares of the company, with 41,884 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1672619/000153636826000007/xslF345X05/form4-07082026_090742.xml

Related Articles

Insider Trading

Immunome Insider Sold Shares Worth $1,244,331, According to a Recent SEC Filing

Robert Lechleider, Chief Medical Officer, on July 02, 2026, sold 55,000 shares in Immunome (IMNM) for $1,244,331. Following the Form 4 filing with the SEC, Lechleider has control over a total of 15,805 common shares of the company, with 15,805 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1472012/000199758426000004/xslF345X05/form4-07072026_090711.xml

$IMNM
Insider Trading

Roku Insider Sold Shares Worth $2,926,798, According to a Recent SEC Filing

Charles Collier, President, Roku Media, on July 06, 2026, sold 20,538 shares in Roku (ROKU) for $2,926,798. Following the Form 4 filing with the SEC, Collier has control over a total of 15,200 Class A common shares of the company, with 15,200 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1428439/000195166526000018/xslF345X05/form4.xml

$ROKU
Insider Trading

TD Synnex Insider Sold Shares Worth $1,214,858, According to a Recent SEC Filing

Richard T Hume, Director, on July 06, 2026, sold 5,000 shares in TD Synnex (SNX) for $1,214,858. Following the Form 4 filing with the SEC, Hume has control over a total of 18,537 common shares of the company, with 18,537 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1177394/000117739426000078/xslF345X05/wk-form4_1783459126.xml

$SNX